Colin Kerr
EuroTimes articles by Colin Kerr
-
New Concept Monofocal IOL with Continuous Focus
Friday, November 1, 2019In this supplement, published by EuroTimes and sponsored by Santen, leading ophthalmologists discuss their experiences with the the xact™ Mono-EDoF™ lens from Santen, describing the unique optical properties of the lens, first as assessed in a laboratory, and the confirmation of the IOL’s extended range of focus in the first clinical trials with the lens […]
-
Clinical study services
Friday, November 1, 2019Medeuronet, a medical device consulting firm focused on European market entry, has acquired the clinical study business assets from IROC Science in a private transaction. IROC Science (Zug, Switzerland) will continue to operate, focusing on developing ophthalmology products, collaborating with medeuronet until companies are ready to go to market. “After collaborating on ophthalmology projects over […]
-
New cross-linking technology
Friday, November 1, 2019Avedro showcased early data on its novel Boost Epi-On cross-linking (CXL) technology for the treatment of keratoconus during an educational session at the 37th Congress of the ESCRS in Paris, France. Presentations highlighted the positive early clinical experiences of several clinicians from different countries who have evaluated Boost Epi-On CXL, a non-invasive corneal CXL procedure […]
-
Innovation comes in many forms, helping patients to see better, connect better and live better
Friday, November 1, 2019Johnson & Johnson Vision announced a series of new products and innovations at the 2019 American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, CA, USA. The company announced the US Food & Drug Administration (FDA) approval of the iDESIGN Refractive Studio Wavefront-guided PRK indication and the availability of TECNIS Simplicity Delivery System. “Innovation […]
-
New office opens in China
Friday, November 1, 2019EyeKor, Inc., an imaging and data management company for the ophthalmic pharmaceutical clinical trial and ocular preclinical laboratory industries, has announced that it is opening a new office in China to enhance its capability to provide local support for clinical trial sponsors and sites in China and the APAC region. “Over the past few years, […]
-
ESCRS 2018 CLINICAL TRENDS SURVEY RESULTS
Friday, November 1, 2019This supplement contains the results of the 2018 ESCRS Clinical Trends Survey, conducted at the 36th Congress of the ESCRS in Vienna, Austria. Delegates also had the option of taking the survey online at the ESCRS website. Questions addressed several areas of clinical practice, including general cataract surgery, astigmatism and toric IOLs, presbyopia correction, glaucoma […]
-
State-of-the-art optics
Friday, November 1, 2019Ergonomic controls for all slit-lamp functions, including magnification, light filters and a stop brake for movement, are all within easy reach of one hand – meaning you’ll never have to put down your lens or let go of the joystick during patient exams. Carl Zeiss Meditech’s new SL 800 features state-of-the-art optics using apochromatic ZEISS […]
-
Ocular Surface Disease Diagnosis & Management: Special Focus on the Lipid Layer
Friday, November 1, 2019In this supplement, published by EuroTimes in association with the ESCRS Education Forum, we learn about ocular surface disease diagnosis and management, with a special focus on the lipid layer. The supplement includes articles by José L. Güell, Spain; Béatrice Cochener-Lamard, France; Carina Koppen, Belgium; Jose Manuel Benitez del Castillo, Spain; and Serge Doan, France. […]
-
Trifocal Toric fully preloaded IOL lens
Friday, November 1, 2019Rayner launched its fully preloaded RayOne Trifocal Toric IOL at the 37th ESCRS Congress in Paris, France. “At Rayner, we only focus on visual outcomes and aim to offer the best. Our trifocal technology has become the lens of choice for many surgeons thanks to its low light loss and reduced dysphotopsia. The missing piece […]
-
Peter Barry Fellowship
Wednesday, October 16, 2019Fellowship commemorates immense contribution made by the late Peter Barry to ophthalmology
